The fact that grip strength significantly increased from baseline is an important finding I think!
Afamelanotide is the International Nonproprietary Name.[4] History The role of -MSH in promoting melanin diffusion has been known since the 1960s.[5] In the 1980s, scientists at University of Arizona began attempting to develop -MSH and analogs as potential sunless tanning agents, and synthesized and tested several analogs, including melanotan-I.[6] To pursue the tanning agent, melanotan-I was licensed by Competitive Technologies, a technology transfer company operating on behalf of University of Arizona, to an Australian startup called Epitan,[7][6] which changed its name to Clinuvel in 2006.[8] Early clinical trials showed that the peptide had to be injected about ten times a day due to its short half-life, so the company collaborated with Southern Research in the US to develop a depot formulation that would be injected under the skin, and release the peptide slowly

If youor anybody you knowthink this is a superficial thing, because you associate weight loss with something cosmetic and external, she said, noting how that misses the point
Many of the men in the overweight category will have enlarged male breasts (another term for gynecomastia) that will have to be managed after weight loss with semaglutide and other weight loss medications
Monitoring for less common signs of diabetic retinopathy progression, seen in 1.9% of users
Their effectiveness in promoting significant weight loss, combined with cardiovascular benefits and a favorable safety profile, makes them valuable options for many patients struggling with obesity